[go: up one dir, main page]

WO1997006815A3 - Solution rinçante aqueuse pour operations endoscopiques - Google Patents

Solution rinçante aqueuse pour operations endoscopiques

Info

Publication number
WO1997006815A3
WO1997006815A3 PCT/EP1996/003579 EP9603579W WO9706815A3 WO 1997006815 A3 WO1997006815 A3 WO 1997006815A3 EP 9603579 W EP9603579 W EP 9603579W WO 9706815 A3 WO9706815 A3 WO 9706815A3
Authority
WO
WIPO (PCT)
Prior art keywords
molecules
cells
cell adhesion
cavities
aqueous rinsing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1996/003579
Other languages
German (de)
English (en)
Other versions
WO1997006815A2 (fr
Inventor
Andreas Boehle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius SE and Co KGaA
Original Assignee
Fresenius SE and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius SE and Co KGaA filed Critical Fresenius SE and Co KGaA
Publication of WO1997006815A2 publication Critical patent/WO1997006815A2/fr
Publication of WO1997006815A3 publication Critical patent/WO1997006815A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des solutions rinçantes aqueuses s'utilisant pendant et après des opérations endoscopiques, qui contiennent un ou plusieurs oligopeptide(s) ayant la propriété de se fixer sur des molécules d'adhésion cellulaire. Les molécules d'adhésion cellulaire sont des molécules ou des groupes moléculaires qui permettent à des cellules ou à des cellules et diverses structures matricielles d'être en contact mutuel. L'utilisation de ces solutions rinçantes permet d'éviter que des cellules tumorales libérées lors de la résection endoscopique n'adhèrent à la paroi de cavités ou d'organes creux, ce qui réduit sensiblement la fréquence de récidives de carcinomes superficiels des cavités et des organes creux concernés.
PCT/EP1996/003579 1995-08-15 1996-08-13 Solution rinçante aqueuse pour operations endoscopiques Ceased WO1997006815A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19529909A DE19529909C2 (de) 1995-08-15 1995-08-15 Wässrige Spüllösung
DE19529909.4 1995-08-15

Publications (2)

Publication Number Publication Date
WO1997006815A2 WO1997006815A2 (fr) 1997-02-27
WO1997006815A3 true WO1997006815A3 (fr) 1997-03-20

Family

ID=7769478

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/003579 Ceased WO1997006815A2 (fr) 1995-08-15 1996-08-13 Solution rinçante aqueuse pour operations endoscopiques

Country Status (2)

Country Link
DE (1) DE19529909C2 (fr)
WO (1) WO1997006815A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890896B1 (en) 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
GB0313644D0 (en) * 2003-06-12 2003-07-16 Univ Bristol Inhibition of infection
JP2010539023A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト ヒトのニューロペプチドの治療剤としての使用
EP2197463A2 (fr) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG UTILISATION DU PEPTIDE RGDSPASSKP ET OPTIONNELLEMENT DE L'ANGIOTENSIN iI COMME AGENT THERAPEUTIQUE, P.E. POUR LE TRAITEMENT DES INFECTIONS DE S. PNEUMONIAE& xA;
RU2010114061A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) ПРИМЕНЕНИЕ ПЕПТИДА His-Ser-Leu-Gly-Lys-Trp-Leu-His-Pro-Asp-Lys-Phe ИНДИВИДУАЛЬНО ИЛИ В КОМБИНАЦИИ С ПЕПТИДОМ Gly-Arg-Gly-Asp-Asn-Pro-OH В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО СРЕДСТВА

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380370A2 (fr) * 1989-01-26 1990-08-01 The Children's Medical Center Corporation Inhibition de la réapparition des tumeurs apres excision chirurgicale
WO1993008818A1 (fr) * 1991-11-07 1993-05-13 The University Of Southern California Compositions et procedes permettant d'eviter la formation d'adherences

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2625156B2 (ja) * 1988-06-24 1997-07-02 市郎 東 細胞接着活性コア配列の繰り返し構造からなるポリペプチド

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380370A2 (fr) * 1989-01-26 1990-08-01 The Children's Medical Center Corporation Inhibition de la réapparition des tumeurs apres excision chirurgicale
WO1993008818A1 (fr) * 1991-11-07 1993-05-13 The University Of Southern California Compositions et procedes permettant d'eviter la formation d'adherences

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
G.F. WHALEN ET AL.: "Inhibition of Tumor-Cell Attachment to Extracellular Matrix as a Method for Preventing Tumor Recurrence in a Surgical Wound", ANNALS OF SURGERY, vol. 310, no. 6, December 1989 (1989-12-01), pages 758 - 764, XP000616651 *

Also Published As

Publication number Publication date
DE19529909A1 (de) 1997-02-20
DE19529909C2 (de) 1998-04-09
WO1997006815A2 (fr) 1997-02-27

Similar Documents

Publication Publication Date Title
ES2032871T3 (es) Procedimiento para la obtencion de tabletas de agentes de limpieza para lentes de contacto con efecto desinfectante.
CA2208018A1 (fr) Nouveaux sulfonamides
CA2356749A1 (fr) Activateur de colles au cyanacrylate
AU694546B2 (en) Compounds, pharmaceutical composition and diagnostic device comprising same and their use
AU2003301200A1 (en) Device and process for the preparation of autologous thrombin serum
EP0236270A3 (fr) Procédé de préparation de corps contenant une substance active et leur utilisation comme "speckles"
EP1166866A3 (fr) Produits chimiques encapsulés à usage dans des applications à libération retardée et contrôlée
MY119241A (en) Medical material and process for producing the same.
IT1196549B (it) Procedimento per la produzione del fattore di lisi cellule bersaglio (tclf),prodotto ottenuto a suo impiego in terapia clinica,in particolare come agente citolitico antitumurale
ID21393A (id) Asam benzazepinon-n-asetat tersubstitusi-asam fosfonat, proses pembuatan dan obat-obat yang mengandung senyawa ini
ES2037138T3 (es) Acrecentamiento del brillo de revestimientos autodepositados.
WO1997006815A3 (fr) Solution rinçante aqueuse pour operations endoscopiques
WO2002030506A3 (fr) Procede transdermique
AU1520701A (en) Segmented process for cleaning-in-place
CA2265780A1 (fr) Polysaccharides sulfates et leurs utilisations dans les traitements medicaux
NO305552B1 (no) Fluorfenylsubstituerte alkenylkarboksylsyre-guanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum sÕvel som medikament inneholdende dem
BR9917478B1 (pt) processo para a fabricação de folha de liga de alumìnio revestida com polìmero, folha de liga de alumìnio revestida com polìmero.
WO2001096366A3 (fr) Inhibiteurs du facteur de coagulation xa
CA2370314A1 (fr) Eponges de detoxication a reactions multiples pour composes organo-phosphores
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
MA25342A1 (fr) 2,3,-o-derives d'isopropylidene de monosaccharides utilises en tant qu'inhibiteurs d'adhesion de cellules.
ID26292A (id) TURUNAN-TURUNAN BARU ASAM OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] 1,2]DIAZEPINA-1-KARBOKSILAT, PROSES PEMBUATANNYA DAN PENGGUNANNYA DALAM PEMBUATAN SENYAWA-SENYAWA AKTIF SECARA TERAPETIK
NO20001414L (no) FremgangsmÕte ved opprenskning av antitrombin III
ES2176349T3 (es) Proceso de sililacion.
AU3378793A (en) New sulfated diosmin derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): BR JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): BR JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase